Financial Performance - Total revenue for Q3 2024 increased by 33% year-over-year to $28.1 million, up from $21.1 million in the prior-year period[3] - Adjusted net income grew 65% year-over-year to $14.9 million, compared to $9.0 million in the prior-year period, with adjusted diluted earnings per share at $0.20[3] - Adjusted EBITDA rose 54% year-over-year to $16.7 million, with an adjusted EBITDA margin of 59.2%, compared to 51.1% in the prior-year period[3] - Total revenues for Q3 2024 reached $28.15 million, a 33.2% increase from $21.12 million in Q3 2023[20] - Active management revenue increased to $26.97 million in Q3 2024, up 42.5% from $18.93 million in Q3 2023[20] - Adjusted Net Income for Q3 2024 was $14.88 million, compared to $9.02 million in Q3 2023, reflecting a 64.5% increase[21] - Adjusted EBITDA for Q3 2024 was $16.67 million, with an Adjusted EBITDA margin of 59.2%, compared to 51.1% in Q3 2023[23] - Net loss attributable to common stockholders for Q3 2024 was $5.13 million, compared to a profit of $0.90 million in Q3 2023[21] - Total operating expenses for Q3 2024 were $19.11 million, an increase from $11.46 million in Q3 2023[20] - The company reported a loss on change in fair value of warrant liability of $8.77 million in Q3 2024, compared to a loss of $0.94 million in Q3 2023[20] Growth and Expansion - The number of policy originations increased by 54% to 278 in Q3 2024, compared to 181 in the prior-year period, with origination capital deployment reaching $93.2 million[3] - The company expects to close acquisitions of Carlisle Management and FCF Advisors, adding approximately $2.6 billion in assets under management by the end of Q4 2024, subject to regulatory approval[2] - The ABL Tech platform serves over 20 clients, with 23 more in negotiations, demonstrating significant growth since its launch eight months ago[2] Returns and Capital - Annualized return on invested capital (ROIC) for Q3 2024 was 21%, while annualized return on equity (ROE) was 23%[3] - Adjusted Annualized Return on Invested Capital (ROIC) improved to 20.6% as of September 30, 2024, up from 18.0% as of June 30, 2024[24] - Adjusted Annualized Return on Equity (ROE) increased to 23.1% for the period ended September 30, 2024, compared to 18.4% for the period ended June 30, 2024[25] Cash and Assets - As of September 30, 2024, the company had cash and cash equivalents of $19.4 million and total assets of $477.3 million[4][18] Product Development - The company launched PREADISAN™, a health prediction and actuarial technology tool, in partnership with Lorisco, aimed at enhancing longevity forecasting[2]

Revenue Growth - Total revenues for the three months ended June 30, 2024, were $29,076,102, a significant increase from $11,378,765 in the same period of 2023, representing a growth of 155.5%[200] - Active management revenue rose to $27,013,757 for the three months ended June 30, 2024, compared to $11,024,399 in 2023, marking an increase of 145.1%[200] - Portfolio servicing revenue increased by 240.5% to $84,218 for the three months ended June 30, 2024, up from $24,737 in 2023, driven by a rise in serviced policies[204] - Origination revenue reached $1,857,457 for the three months ended June 30, 2024, compared to $0 in the same period in 2023, related to the acquisition of Abacus[210] - Total revenue for the active management segment increased by $15,989,358 or 145.0% for the three months ended June 30, 2024, compared to the same period in 2023[249] - Total revenue for the originations segment increased by $1,857,457 for the three months ended June 30, 2024, compared to the same period in 2023, with no prior revenue recorded[251] Profitability - Gross profit for the three months ended June 30, 2024, was $26,332,568, compared to $10,405,365 in 2023, reflecting a growth of 153.3%[200] - Gross profit increased by $15,927,203, or 153.1%, for the three months ended June 30, 2024, primarily due to an increase in active management revenue driven by an increase in policies purchased[217] - For the three months ended June 30, 2024, the adjusted net income was $11,812,527, compared to $6,750,145 for the same period in 2023, reflecting a significant increase[260] - The adjusted EPS for the three months ended June 30, 2024, was $0.19 (basic) and $0.18 (diluted), compared to $0.13 (basic and diluted) in 2023[260] - Adjusted EBITDA for the three months ended June 30, 2024, was $16,716,882, up from $9,143,985 in 2023, with an adjusted EBITDA margin of 57.5% compared to 80.4% in 2023[265] Expenses - Operating income for the three months ended June 30, 2024, was $6,770,770, a decrease from $8,370,594 in the same period of 2023[200] - Sales and marketing expenses surged by $1,868,960, or 273.3%, for the three months ended June 30, 2024, primarily due to increased advertising costs to support origination and active management growth strategies[220] - General and administrative expenses increased by $13,975,805, or 2,419.9%, for the three months ended June 30, 2024, largely due to non-cash stock-based compensation and payroll expenses[222] - Cost of revenue (excluding depreciation and amortization) increased by $1,768,681, or 181.7%, for the three months ended June 30, 2024, primarily due to increased payroll and commission expenses[213] Investment Performance - Unrealized loss on investments increased by $1,035,418, or 153.9%, for the three months ended June 30, 2024, primarily due to changes in the fair value of S&P 500 options[226] - Unrealized gain on investments increased by $4,328 or 0.5% for the six months ended June 30, 2024, compared to the same period in 2023[227] - Realized gain on investments increased by $856,744 for the three months ended June 30, 2024, compared to the same period in 2023, primarily due to the sale of S&P 500 options[228] Cash Flow - Net cash used in operating activities for the six months ended June 30, 2024, was $(64,542,510), an increase of $(26,178,339) compared to $(38,364,171) in 2023[275] - Net cash provided by financing activities surged to $130,993,784 for the six months ended June 30, 2024, compared to $35,983,097 in 2023, marking an increase of $95,010,687[279] - The company believes its current cash and cash equivalents will be sufficient to support operating and debt service needs for the next 12 months[274] Policy and Market Activity - The number of policies serviced increased by 41.0% to 1,155 for the six months ended June 30, 2024, from 819 in 2023[270] - The value of policies serviced rose to $2,526,819,484 for the six months ended June 30, 2024, a 38.6% increase from $1,823,437,795 in 2023[270] - Total invested dollars increased by 59.4% to $1,081,579,116 for the six months ended June 30, 2024, compared to $678,400,432 in 2023[270] Related Party Transactions - Related-party revenue for the three months ended June 30, 2023 included $1,579,864 from 38 originated policies for the Nova funds, valued at $56,688,680[292] - Related-party revenue for the six months ended June 30, 2023 included $3,093,797 from 72 originated policies for the Nova funds, valued at $96,674,080[294] Other Financial Metrics - Interest expense increased to $4,529,187 for the three months ended June 30, 2024, compared to $584,075 for the same period in 2023, primarily due to various interest expenses[234] - Income tax expense increased by $573,139 or 48.4% for the three months ended June 30, 2024, compared to the same period in 2023[242] - Other income (expense) decreased by $73,869 or 60.7% for the three months ended June 30, 2024, compared to the same period in 2023[233]

As filed with the Securities and Exchange Commission on June 13, 2024. Registration No. 333-279347 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 6282 85-1210472 (Primary Standard Industrial Classification Code Number) 2101 Park Center Drive, Suite 200 Orlan ...

As filed with the Securities and Exchange Commission on May 30, 2024. Registration No. 333-279347 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 6282 85-1210472 (Primary Standard Industrial Classification Code Number) 2101 Park Center Drive, Suite 170 Orland ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 85-1210472 ...

As filed with the Securities and Exchange Commission on May 10, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 6282 85-1210472 (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) Orlando, Florida 32835 (8 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Life, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdic ...

Table of Contents As filed with the Securities and Exchange Commission on February 9, 2024. Registration No. 333-276795 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 6282 85-1210472 (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Id ...

Table of Contents As filed with the Securities and Exchange Commission on January 31, 2024. Registration No. 333-[ ] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 6282 85-1210472 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) 2101 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 85-1210472 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 2101 Park Center Drive, Suite 170 O ...